Reports for TEVETEN PLUS
Brand name
TEVETEN PLUS
Company Name
BGP PHARMA ULC
|
Drug Identification Number
02253631 |
Ingredients
HYDROCHLOROTHIAZIDE EPROSARTAN |
Ingredient Strength
12.5 MG 600 MG |
ATC Code
C09DAC09DA C09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
CANCELLED POST MARKET
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVETEN PLUS | 2x14CA | Resolved | 2018-11-08 | 2019-01-16 | 66450 |
TEVETEN PLUS | 2 x 14CA | Resolved | 2019-01-18 | 2019-04-04 | 72948 |
TEVETEN PLUS | 2x14CA | Resolved | 2019-11-28 | 2020-07-16 | 99916 |
TEVETEN PLUS | 2x14 | Avoided shortage | 2020-07-16 | 2020-08-04 | 120414 |
TEVETEN PLUS | 2x14 | Avoided shortage | 2020-09-22 | 2020-09-29 | 124719 |
TEVETEN PLUS | 3x10 | Resolved | 2020-10-06 | 2020-11-03 | 125760 |
TEVETEN PLUS | 2x14 | Resolved | 2022-09-13 | 2024-12-10 | 169169 |
Showing 1 to 7 of 7
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVETEN PLUS | 2x14 | Discontinued | 2024-12-10 | 2024-12-10 | 245261 |
Showing 1 to 1 of 1